The AJCC TNM staging system is the prevailing method in prognostic evaluation of pancreatic ductal adenocarcinoma (PDAC) at present , but it did not include factors such as the tumor immune microenvironment that are known to exert a profound impact on patients'clinical outcome. This study was aimed to develop a comprehensive and effective prognostic score model to predict prognosis and guide clinical management for postoperative PDAC patients.
Study Type
OBSERVATIONAL
Enrollment
302
Surgical resection of pancreatic cancer，including radical or palliative surgery
First Affiliated Hospital, Medical College of Zhejiang University
Hangzhou, Zhejiang, China
overall survival
the number of months from the date of surgery to the date of the last follow-up visit or time of death.
Time frame: after pancreatic cancer surgery until october 31, 2020
disease-free survival disease-free survival disease-free survival disease-free survival
the number of months from the date of surgery to the date of first confirmable recurrence or death
Time frame: after pancreatic cancer surgery until october 31, 2020
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.